Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2014 Jun;25(6):1137-9.
doi: 10.1681/ASN.2014010091. Epub 2014 Mar 7.

Phospholipase A2 receptor antibodies in membranous nephropathy: unresolved issues

Affiliations
Editorial

Phospholipase A2 receptor antibodies in membranous nephropathy: unresolved issues

Julia M Hofstra et al. J Am Soc Nephrol. 2014 Jun.
No abstract available

Keywords: aPLA2R; membranous nephropathy.

PubMed Disclaimer

Comment on

References

    1. Beck LH, Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361: 11–21, 2009 - PMC - PubMed
    1. Hofstra JM, Wetzels JF: Anti-PLA₂R antibodies in membranous nephropathy: Ready for routine clinical practice? Neth J Med 70: 109–113, 2012 - PubMed
    1. Debiec H, Ronco P: Nephrotic syndrome: A new specific test for idiopathic membranous nephropathy. Nat Rev Nephrol 7: 496–498, 2011 - PubMed
    1. Hoxha E, Kneißler U, Stege G, Zahner G, Thiele I, Panzer U, Harendza S, Helmchen UM, Stahl RA: Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Kidney Int 82: 797–804, 2012 - PubMed
    1. Hofstra JM, Beck LH, Jr, Beck DM, Wetzels JF, Salant DJ: Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 6: 1286–1291, 2011 - PMC - PubMed

LinkOut - more resources